Melissa Fassbender

Founded by an interventional cardiologist at the University of Chicago, Parasol has developed a novel, minimally invasive device to reduce the risk of stroke in patients with atrial fibrillation.

Alchemist Accelerator and the University of Chicago's Polsky Center for Entrepreneurship and Innovation are thrilled to announce the inaugural cohort of Alchemist Chicago.

The new cohort of the Polsky Science and Technology Associates includes three University of Chicago graduate students who are working with the Polsky Center's technology and business development teams to support many aspects of the technology commercialization process.

The spring 2026 George Shultz Innovation Fund finalists are developing novel software, medical devices, and therapeutics.

Cofounded at the University of Chicago, Quantum spin-out memQ has raised $10 million in a Series A round to fuel new stage of growth.

CavilinQ has raised $8.8 million in seed funding to develop scalable quantum computing architecture based on pioneering research at the University of Chicago.

The George Shultz Innovation Fund has selected two University of Chicago startups, Parasol Medtech and Signl, for an investment of $250,000 each.

Kompass Diagnostics is developing a next-generation diagnostic platform based on research at the University of Chicago and has secured an exclusive license as it looks to bring the technology to patients.

Enemsa Pharma has been granted exclusive patent rights from the University of Chicago to use a family of small molecules for the treatment of demyelinating diseases.

The Entrepreneurship for Science and Medicine course gives University of Chicago graduate students, postdocs, and faculty the opportunity to explore the intersection of science and business.